Catalent Pharma Solutions’s New Injectables Facility Completes First Flu Vaccine Manufacturing Campaign

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, one of the leading providers of advanced dose form and packaging technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies, today announced the successful completion of the first influenza vaccine manufacturing campaign from its new prefilled syringe manufacturing facility in Neder-Over-Heembeek, near Brussels, Belgium.

MORE ON THIS TOPIC